OWP Pharmaceuticals Partners with EVERSANA for Launch of SUBVENITE® in the US Market OWP Pharmaceuticals has teamed up with EVERSANA to facilitate the U.S. launch of SUBVENITE® oral suspension, a breakthrough treatment for epilepsy and bipolar disorders.

OWP Pharmaceuticals Partners with EVERSANA for Launch of SUBVENITE® in the US Market #United_States #Lisle #EVERSANA #SUBVENITE® #OWP_Pharmaceuticals